Fasano, Alfonso
 Distribuzione geografica
Continente #
EU - Europa 3.090
NA - Nord America 2.689
AS - Asia 535
AF - Africa 29
OC - Oceania 14
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.369
Nazione #
US - Stati Uniti d'America 2.672
DE - Germania 1.256
SE - Svezia 513
CN - Cina 366
UA - Ucraina 333
IT - Italia 237
FR - Francia 199
IE - Irlanda 157
GB - Regno Unito 156
IN - India 74
FI - Finlandia 71
PL - Polonia 60
RU - Federazione Russa 38
TR - Turchia 26
CI - Costa d'Avorio 21
JP - Giappone 20
NL - Olanda 16
BE - Belgio 14
AU - Australia 13
IR - Iran 12
CA - Canada 10
SG - Singapore 10
HK - Hong Kong 9
ES - Italia 7
MX - Messico 6
AT - Austria 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CH - Svizzera 4
EU - Europa 4
IL - Israele 4
KE - Kenya 4
BR - Brasile 3
GR - Grecia 3
KR - Corea 3
VN - Vietnam 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
HU - Ungheria 2
PT - Portogallo 2
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
KZ - Kazakistan 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
TW - Taiwan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 6.369
Città #
Chandler 589
Ashburn 211
Jacksonville 170
Dublin 154
San Mateo 145
Nanjing 97
Wilmington 93
Ann Arbor 79
New York 75
Nürnberg 75
Dearborn 70
Woodbridge 65
Boston 62
Lawrence 58
Warsaw 56
Houston 54
Seattle 48
Fairfield 46
Lancaster 42
Marseille 42
Milan 42
Beijing 41
Nanchang 38
Redwood City 35
Cattolica 33
Munich 28
Redmond 27
University Park 26
Mountain View 25
Norwalk 24
Princeton 24
Bremen 22
Izmir 22
Jiaxing 22
Shenyang 22
Abidjan 21
Leawood 20
Rome 20
Changsha 18
Hangzhou 17
Hebei 17
Boardman 15
Brussels 14
Shanghai 14
Tianjin 14
Fremont 13
Pune 13
Cambridge 12
London 12
Simi Valley 12
Kunming 11
Zhengzhou 11
Chicago 10
Augusta 9
Poitiers 9
Los Angeles 8
Falls Church 7
Phoenix 7
Columbus 6
Detroit 6
Guangzhou 6
Fuzhou 5
Helsinki 5
Lanzhou 5
Taizhou 5
Tehran 5
Toronto 5
Vienna 5
Brisbane 4
Bronxville 4
Chelmsford 4
Chennai 4
Costa Mesa 4
Dubai 4
Fort Worth 4
Hong Kong 4
Jinan 4
Locarno 4
Amsterdam 3
Andover 3
Berlin 3
Castelfidardo 3
Central 3
Chengdu 3
Cologne 3
Edinburgh 3
Gergei 3
Hefei 3
Mexico 3
Padova 3
Philadelphia 3
São Paulo 3
Tappahannock 3
Tokyo 3
Ardabil 2
Athens 2
Atlanta 2
Battipaglia 2
Brindisi 2
Budapest 2
Totale 3.119
Nome #
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 189
The role of small intestinal bacterial overgrowth in Parkinson's disease 174
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 140
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 131
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. 128
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 121
PUNDING IN PARKINSON'S DISEASE: THE IMPACT OF PATIANT'S AWARENESS ON DIAGNOSIS 120
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 118
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study 118
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 111
Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease 107
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 106
Prevalence of small intestinal bacterial overgrowth in Parkinson's disease 104
Unilateral extradural motor cortex stimulation is safe and improves Parkinson disease at 1 year 104
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 102
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 98
Movement disorders in multiple sclerosis: Causal or coincidental association? 98
Aristotle's illusion reveals interdigit functional somatosensory alterations in focal hand dystonia 96
Dystonia gravidarum: a new case with a long follow-up 95
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 94
Analysis of blink rate in patients with blepharospasm 94
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 94
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 94
Depression Symptoms and Clinical Subtypes in Parkinson's Disease Patients: a I-123-FP-CIT SPECT Study 89
Tourettism in multiple sclerosis: a case report 87
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 87
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report 86
Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability 86
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT study: reply to comment by Erro et al. 86
MANAGEMENT OF PUNDING IN PARKINSON'S DISEASE: AN OPEN-LABEL PROSPECTIVE STUDY 85
Homotoxicology remedies versu desmopressin versus placebo in the treatment of enuresis: a randomised, double-blind, controlled trial. 84
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 84
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 84
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 83
Alpha-synuclein gene duplication: marked intrafamilial variability in two novel pedigrees 83
Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis 82
GPi-DBS in Huntington's disease: results on motor function and cognition in a 72-year-old case 82
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 81
Reliability of Clinical Diagnosis of Dystonia 81
New olfactometric findings in Parkinson's disease 81
Reduced facial expressiveness in Parkinson's disease: A pure motor disorder? 79
Working on asymmetry in Parkinson's disease: randomized, controlled pilot study 79
Management of status dystonicus: our experience and review of the literature 78
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis 78
Safety and efficacy of rotigotine in individuals with Parkinson's disease aged 75 and older 75
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity 74
Punding and computer addiction in Parkinson's disease 73
The long-term effect of tetrabenazine in the management of Huntington disease 73
Freezing of gait in Parkinson's disease: the paradoxical interplay between gait and cognition 71
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 71
RARE AND SERIOS CARDIAC SIDE EFFECTS DURING ROPINIROLE TITRATION 70
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 70
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 69
Onset and progression of primary torsion dystonia in sporadic and familial cases 67
Acute necrotizing encephalopathy: a relapsing case in a European adult 67
Humanitarian mission improves health conditions of schoolchildren in Ethiopia. the case of Adwa 67
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 63
Increased excretion of glycosaminoglycans in children with urinary incontinence compared to those with monosymptomatic nocturnal enuresis 63
Rare and serious cardiac side effects during ropinirole titration 62
Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding 62
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 60
Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study 59
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 58
Movement disorders phenomenology in focal motor seizures 56
Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life 52
Long-term consequences of optical coherence tomography findings during percutaneous coronary intervention: The Centro per la Lotta Contro L'infarto - Optimization of Percutaneous Coronary Intervention (CLI-OPCI) LATE study 51
Status dystonicus: predictors of outcome and progression patterns of underlying disease 50
Functional disorders after COVID-19 vaccine fuel vaccination hesitancy 50
Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion 49
Punding (PD) 46
Long-term effects of pedunculopontine nucleus stimulation for pisa syndrome 46
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 46
Treatment of dystonia using trihexyphenidyl in costello syndrome 42
Randomized comparison of optical coherence tomography versus angiography to guide Bioresorbable vascular scaffold implantation: The OPTICO BVS study 41
Retrospective evaluation of the dose equivalence of Botox and Dysport in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story 40
Role of optical coherence tomography for distal left main stem angioplasty 40
Tetrabenazine 39
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts 38
Pisa syndrome in Parkinson disease 38
Implementation of the Current Dystonia Classification from 2013 to 2018 35
Psychogenic facial movement disorders: Clinical features and associated conditions 32
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long-term clinical trials 12
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: From the advanced phase towards the late stage of the disease? 3
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease. 1
Totale 6.462
Categoria #
all - tutte 21.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019152 0 0 0 0 0 0 0 0 0 36 56 60
2019/2020968 209 44 54 59 50 82 89 51 55 59 118 98
2020/2021801 61 83 10 75 94 33 75 27 104 81 143 15
2021/2022810 67 81 20 45 46 26 21 126 35 69 118 156
2022/20231.606 190 217 123 232 118 202 83 145 194 21 59 22
2023/2024538 39 215 21 31 13 110 38 36 11 24 0 0
Totale 6.462